Retinoids in Oncology

  • Laurent Degos
  • David R. Parkinson
Conference proceedings

Part of the ESO Monographs book series (ESO MONOGRAPHS)

Table of contents

  1. Front Matter
    Pages I-VII
  2. Laurent Degos, David R. Parkinson
    Pages 1-2
  3. Arthur Zelent
    Pages 3-25
  4. Reuben Lotan
    Pages 27-42
  5. Gillian Morriss-Kay
    Pages 43-53
  6. Ugo Pastorino, Raymond P. Warrell Jr., Franca Formelli
    Pages 55-66
  7. Raymond P. Warrell Jr, Ugo Pastorino, Andrea Decensi
    Pages 67-71
  8. Hugues de Thé, Laurent Degos, Raymond P. Warrell Jr
    Pages 73-88
  9. David R. Parkinson, Raymond P. Warrell Jr
    Pages 89-92
  10. Ugo Pastorino, David R. Parkinson, Fausto Chiesa
    Pages 93-111
  11. Laurent Degos, David R. Parkinson
    Pages 113-115

About these proceedings


Recent developments with respect to the biology and clinical use of retinoids in cancer therapy and prevention are comprehensively covered by experts in this new field. Newer aspects of molecular mechanisms of retinoid effects, the cellular biology and the developmental effects of these compounds are presented together with a comprehensive description of the latest findings of retinoid pharmacology, toxicology and clinical effects in a wide range of hematological and solid malignancies.


Chemoprävention Differenzierungstherapie Krebstherapie Leukämie Retinoide cancer treatment chemoprevention differentiation therapy leukemia pharmacology prevention retinoids

Editors and affiliations

  • Laurent Degos
    • 1
  • David R. Parkinson
    • 2
  1. 1.Hôpital St. LouisInstitut Universitaire d’HématologieParisFrance
  2. 2.Investigational Drug Branch, Division of Cancer TreatmentNational Cancer InstituteRockvilleUSA

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1995
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-79708-8
  • Online ISBN 978-3-642-79706-4
  • Buy this book on publisher's site